abstract |
(57) [Summary] [PROBLEMS] To provide a novel therapeutic agent for lymphocytic tumors. SOLUTION: A therapeutic agent for lymphocytic tumors (excluding myeloma), which contains, as an active ingredient, an antibody that specifically binds to a protein having the amino acid sequence shown in SEQ ID NO: 1 and has cytotoxic activity. |